Suppr超能文献

乳头状微癌

Papillary microcarcinoma.

作者信息

Noguchi Shiro, Yamashita Hiroto, Uchino Shinya, Watanabe Shin

机构信息

Noguchi Thyroid Clinic and Hospital Foundation, Beppu, Japan.

出版信息

World J Surg. 2008 May;32(5):747-53. doi: 10.1007/s00268-007-9453-0.

Abstract

BACKGROUND

Papillary microcarcinoma (PMC) is increasing in incidence because of diagnosis by ultrasound-guided fine-needle aspiration cytology.

METHODS

Between January 1966 and December 1995, we treated 6019 patients with papillary cancer; among them, 2070 patients with PMC were studied.

RESULTS

PMC is essentially very similar to papillary cancer that is 11 mm or larger and has a very good prognosis. Smaller tumors and younger patients have a better prognosis. Among PMC, larger tumors (6-10 mm) recur in 14% at 35 years compared with 3.3% in patients with smaller tumors. Patients older than 55 years have recurrence in 40% at 30 years, with a worse prognosis than younger patients who have a recurrence rate of less than 10%. Extracapsular invasion by the primary tumor also has a higher recurrence rate. The majority of recurrences are in the neck. Therefore, annual ultrasound of the neck is effective for recurrence surveillance.

CONCLUSION

Papillary microcarcinoma is similar to larger papillary carcinomas with tumor characteristics and age-based recurrence rate that extends for many years, justifying long surveillance after surgery.

摘要

背景

由于超声引导下细针穿刺细胞学检查的应用,乳头状微癌(PMC)的发病率正在上升。

方法

1966年1月至1995年12月期间,我们治疗了6019例乳头状癌患者;其中,对2070例PMC患者进行了研究。

结果

PMC本质上与直径11毫米或更大的乳头状癌非常相似,预后非常好。肿瘤较小和年龄较轻的患者预后较好。在PMC中,较大的肿瘤(6 - 10毫米)在35年时的复发率为14%,而较小肿瘤患者的复发率为3.3%。55岁以上的患者在30年时的复发率为40%,预后比复发率低于10%的年轻患者更差。原发肿瘤的包膜外侵犯也有较高的复发率。大多数复发发生在颈部。因此,每年进行颈部超声检查对复发监测有效。

结论

乳头状微癌与较大的乳头状癌相似,具有肿瘤特征和基于年龄的复发率,且这种情况会持续多年,这证明了手术后进行长期监测的合理性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6e9/2323028/6609157ad2a9/268_2007_9453_Fig1_HTML.jpg

相似文献

1
Papillary microcarcinoma.
World J Surg. 2008 May;32(5):747-53. doi: 10.1007/s00268-007-9453-0.
2
Routine Prophylactic Central Neck Dissection May Not Obviously Reduce Lateral Neck Recurrence for Papillary Thyroid Microcarcinoma.
ORL J Otorhinolaryngol Relat Spec. 2019;81(2-3):73-81. doi: 10.1159/000497407. Epub 2019 Jun 12.
4
Papillary thyroid microcarcinoma in Denmark 1996-2008: a national study of epidemiology and clinical significance.
Thyroid. 2013 Sep;23(9):1159-64. doi: 10.1089/thy.2012.0595. Epub 2013 Aug 28.
5
High recurrent rate of multicentric papillary thyroid carcinoma.
Ann Surg Oncol. 2009 Sep;16(9):2609-16. doi: 10.1245/s10434-009-0565-7. Epub 2009 Jun 16.
9
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Am J Med. 1994 Nov;97(5):418-28. doi: 10.1016/0002-9343(94)90321-2.

引用本文的文献

2
Mortality rate and causes of death in papillary thyroid microcarcinoma.
Endocrine. 2024 Mar;83(3):671-680. doi: 10.1007/s12020-023-03510-8. Epub 2023 Oct 9.
4
Predictive Factors for Bilateral Disease in Papillary Microcarcinoma: A Retrospective Cohort Study.
Curr Oncol. 2022 Aug 23;29(9):6010-6017. doi: 10.3390/curroncol29090473.
5
Population-level Outcomes of Early Thyroid Cancers: A Need to Revisit Current Practice.
Rambam Maimonides Med J. 2022 Apr 26;13(2):e0008. doi: 10.5041/RMMJ.10467.
6
Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.
Front Endocrinol (Lausanne). 2022 Mar 11;13:808298. doi: 10.3389/fendo.2022.808298. eCollection 2022.
8
Update of Radiofrequency Ablation for Treating Benign and Malignant Thyroid Nodules. The Future Is Now.
Front Endocrinol (Lausanne). 2021 Jun 24;12:698689. doi: 10.3389/fendo.2021.698689. eCollection 2021.
9
Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions.
Front Oncol. 2021 Jun 7;11:580886. doi: 10.3389/fonc.2021.580886. eCollection 2021.
10
Papillary thyroid microcarcinoma with lung metastases: a case report and review of the literature.
Thyroid Res. 2021 Jun 11;14(1):15. doi: 10.1186/s13044-021-00106-0.

本文引用的文献

1
Treatment for microcarcinoma of the thyroid--clinical experience.
Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d.
3
Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients.
Eur J Surg Oncol. 2006 Dec;32(10):1144-8. doi: 10.1016/j.ejso.2006.07.001. Epub 2006 Jul 26.
7
Biologic basis for the treatment of microscopic, occult well-differentiated thyroid cancer.
Surgery. 2001 Dec;130(6):1050-4. doi: 10.1067/msy.2001.118389.
8
Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome.
Surgery. 1999 Dec;126(6):1070-6; discussion 1076-7. doi: 10.1067/msy.2099.101431.
9
Good prognosis in thyroid cancer found incidentally at surgery for thyrotoxicosis.
Postgrad Med J. 1999 Mar;75(881):169-70. doi: 10.1136/pgmj.75.881.169.
10
Clinical review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors.
J Clin Endocrinol Metab. 1999 Mar;84(3):829-34. doi: 10.1210/jcem.84.3.5519.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验